Top Abstract Purchase Related
Home
>
Node
>
Subnode

MicroRNA in prostate cancer

Nakagawa, M.

Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2224-2228

2014

ISSN/ISBN: 0047-1852
PMID: 25518362
Document Number: 675106
MicroRNAs are small non-coding RNAs that negatively regulate gene expression post-transcriptionally. MicroRNA profiles have been studied in various cancers including prostate cancer since 2007. According to these results, microRNA signature in prostate cancer differed from their normal counterparts, suggesting that the differential expression of microRNAs in tumors functionally implicated in their pathogenesis. The up-regulation of oncogenic microRNA and down-regulation of tumor suppressor microRNA are demonstrated in various cancers. The target genes of microRNA identified include those of apoptosis avoidance, cell proliferation, epithelial mesenchymal transition, angiogenic signalling, and generation of androgen independence in prostate cancer. Elucidation of micro RNA function may provide further advance in diagnosis and treatment of prostate cancer.

Document emailed within 1 workday
Secure & encrypted payments

Zhang, X.; Jin, K.; Luo, J.D.; Liu, B.; Xie, L.P. 2019: MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1 Neoplasma 2019
Li, Y.; Yue, H.-y.; Liu, W.-t.; Fang, W.-l. 2011: DNA methylation of microRNA-34b/c and microRNA-124a in gastric cancer Zhonghua Yi Xue Za Zhi 91(23): 1640-1642
Alberti, C. 2016: Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications European Review for Medical and Pharmacological Sciences 20(6): 1001-1002
Sheneef, A.; Gouda, A.M.; Mohammad, A.N.; Yousef, L.M.; Noureldin, A.K. 2017: Serum MicroRNA-122 and MicroRNA-155: Markers of Disease Progression in Hepatitis C viral infection Egyptian Journal of Immunology 24(2): 33-46
Zhang, C.-z.; Kang, C.-s.; Pu, P.-y.; Wang, G.-x.; Jia, Z.-f.; Zhang, A.-l.; Han, L.; Xu, P. 2009: Inhibitory effect of knocking down microRNA-221 and microRNA-222 on glioma cell growth in vitro and in vivo Zhonghua Zhong Liu Za Zhi 31(10): 721-726
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Zhang, S.; Yuan, W.; Tang, W.; Xu, C.; Ma, J. 2015: Expression of microRNA-100 and its relation with prognosis of colorectal cancer Zhonghua Zhong Liu Za Zhi 37(8): 603-608
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Ashizawa, M.; Okayama, H.; Aung Kyi Thar Min; Noda, M.; Aoto, K.; Nakajima, T.; Ishigame, T.; Mimura, K.; Kono, K. 2017: Regulation of PD-L1 by MicroRNA in Mismatch Repair Deficient-Colorectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(10): 889-891
Takahashi, R.-u.; Makiko, O.; Ochiya, T. 2012: Role of microRNA in cancer development: biology and clinical applications Nihon Geka Gakkai Zasshi 113(2): 197-203
Zhang, P.; Ma, F.; Xu, B. 2015: Polymorphisms of microRNA genes and their association with breast cancer risk Zhonghua Zhong Liu Za Zhi 37(7): 501-507
Xu, X.-C.; Zhang, Y.-H.; Zhang, W.-B.; Li, T.; Gao, H.; Wang, Y.-H. 2014: MicroRNA-133a functions as a tumor suppressor in gastric cancer Journal of Biological Regulators and Homeostatic Agents 28(4): 615-624